Anisina confirmed as effective anti-cancer agent in preclinical studies
14 May 2015 | By Victoria White
Novogen has confirmed that drug candidate, Anisina, is an effective monotherapy against human melanoma in an animal model...
List view / Grid view
News
Acucela announces publication of preclinical data for emixustat
14 May 2015 | By Victoria White
Acucela has announced the publication of preclinical data related to the Company’s investigational drug candidate emixustat hydrochloride...
Antibiotic Research UK welcomes the O’Neill Commission’s recommendation to create $2b global fund to tackle antibiotic resistance
14 May 2015 | By Victoria White
Antibiotic Research UK has welcomed this latest report to come from Jim O’Neill's Review on Antimicrobial Resistance and has endorses its recommendations...
Immunomic Therapeutics awarded $1.2m to develop peanut allergy treatment
13 May 2015 | By Victoria White
Immunomic Therapeutics has been awarded a US $1.2 million grant for the development of its ARA-LAMP-vax technology against peanut allergies...
Sanofi exercises option on second therapeutic programme with Selecta Biosciences to develop a treatment for coeliac disease
13 May 2015 | By Victoria White
Under the terms of an existing agreement with Selecta, Sanofi has exercised its option to an exclusive license to develop a treatment of coeliac disease...
Genethon and Selecta Biosciences to research repeat dosing for gene therapies
13 May 2015 | By Victoria White
Genethon and Selecta Biosciences have announced an ongoing research collaboration with the goal of enabling repeat dosing for gene therapies...
Soligenix enters agreement with Emergent BioSolutions to develop ricin vaccine RiVax
13 May 2015 | By Victoria White
Soligenix has initiated a development agreement with Emergent BioSolutions to implement a commercially viable, scalable production technology for RiVax...
Invectys initiates Phase I clinical trial evaluating INVAC-1 therapeutic vaccine for cancer patients
13 May 2015 | By Victoria White
A Phase I clinical trial of INVAC-1, an innovative therapeutic DNA vaccine, which specifically targets the telomerase enzyme (hTERT), has commenced...
New “map” of TTLL7 protein helps researchers understand cellular transport
12 May 2015 | By
Scientists from TSRI and NIH have mapped out the structure of an important protein involved in cellular function and nervous system development - TTLL7...
Significant progress made towards individualised cancer immunotherapy
12 May 2015 | By Victoria White
Mainz-based researchers have made significant advances with regard to the development of individualised cancer immunotherapy strategies...
Haplogen and Cyclenium Pharma announce research and development collaboration
12 May 2015 | By Victoria White
Cyclenium Pharma and Haplogen have signed a research agreement aimed at the discovery of novel pharmaceutical candidates in multiple disease areas...
BioNTech and Lilly enter into cancer immunotherapy research collaboration
12 May 2015 | By Victoria White
BioNTech and Lilly are to collaborate to identify and validate novel tumour targets and their corresponding TCRs in one or more types of cancer...
FDA grants QIDP and Fast Track Designations to CD101 IV for the treatment of candidemia
11 May 2015 | By Victoria White
Cidara Therapeutics has announced that the FDA has designated the Company’s lead antifungal product candidate, CD101 IV, as a QIDP with Fast Track status...
Studies confirm TRXE-009 kills resistant paediatric brain cancer cells
11 May 2015 | By Victoria White
Novogen, in conjunction with Australian paediatric cancer researchers, released key preclinical data on experimental cancer drug-candidate, TRXE-009...
GSK partners with UNC-Chapel Hill to accelerate search for HIV cure
11 May 2015 | By Victoria White
UNC-Chapel Hill and GSK have announced the creation of a dedicated HIV Cure centre and a new company that will focus on discovering a cure for HIV/AIDS...